Summary
Adenosine has a negative inotropic effect in cardiacatrial preparations (“direct” negative inotropic effect). This effect is probably due to an activation of a potassium outward current which shortens the action potential duration and hence reduces the force of contraction. A pertussis toxin-sensitive N-protein is involved in the signal transduction from the adenosine receptor to atrial potassium channels. Inventricular cardiac preparations adenosine has no negative or even a weak positive inotropic effect, but it reduces the force of contraction in the presence of cAMP-increasing agents such as isoprenaline (“indirect” negative inotropic effect). This effect is due to an inhibition of the slow Ca2+ inward current which has previously been enhanced by an increase in the cellular cAMP content. This “indirect” negative inotropic effect of adenosine is also present in the human heart. Since increased amounts of adenosine are released during cardiac stimulation via β-adrenoceptors, the “indirect” effect might protect the heart against excessive stimulation by catecholamines. In addition, adenosine has negative chronotropic actions and prolongs AV conduction by an activation of potassium channels or an inhibition of the slow Ca2+ inward current (AV node). Cardiac bradyarrhythmias in hypoxia have been attributed to an increased formation and release of adenosine. Furthermore, adenosine has been shown to terminate supraventricular tachycardias involving the AV node. Since it has a very short duration of action it might prove safe and hence advantageous to conventional therapy in the treatment of supraventricular tachycardias.
Zusammenfassung
Zusammenfassend läßt sich sagen, daß Adenosin am Vorhof negativ inotrop wirkt (direkter negativ inotroper Effekt). Am Ventrikel wirkt Adenosin nur bei Erhöhung des zellulären cAMP-Gehaltes durch Stimulation der Adenylatcyclase oder Hemmung der Phosphodiesterase negative inotrop (indirekter negative inotroper Effekt). Diese Wirkung ist von einer Abnahme des langsamen Ca2+-Einwärtsstromes begleitet. Ob diese Abnahme mit einer Hemmung der Adenylatcyclase erklärt werden kann oder ob Mechanismen, die der cAMP-Bildung nachgeschaltet sind (z.B. Hemmung cAMP-abhängiger Proteinkinasen, Aktivierung von Proteinphosphatasen), eine Rolle spielen, ist bisher umstritten. Der indirekte negativ inotrope Effekt konnte kürzlich auch an isoliertem menschlichen Ventrikelmyokard nachgewiesen werden, so daß Adenosin möglicherweise auch am menschlichen Herzen eine Rolle als physiologischer Feedback-Hemmstoff bei exzessiver Katecholaminstimulation und bei Hypoxie spielen könnte. Diese Hemmung einer Stimulation kardialer β-Adrenozeptoren könnte eine antiarrhythmische Wirkung bei katecholamininduzierten Tachyarrhythmien bewirken. Eine defekte adenosinvermittelte Regulation des Herzens könnte schließlich auch eine Bedeutung in der Pathogenese von Herzerkrankungen wie der hypertrophen Kardiomyopathie haben. Hierüber liegen allerdings keine klinischen oder experimentellen Daten vor. Andererseits wirkt Adenosin negativ chronotrop und dromotrop und vermittelt wahrscheinlich bradykarde Herzrhythmusstörungen während myokardialer Hypoxie. Entsprechend seiner negativ dromotropen Wirkung eignet es sich zur Therapie von supraventrikulären Tachykardien mit Beteiligung des AV-Knotens. Seine kurze Wirkdauer läßt es als vorteilhaft gegenüber einer konventionellen Therapie mit Ca2+-Antagonisten erscheinen.
Similar content being viewed by others
Abbreviations
- s:
-
Sekunde
- mN:
-
Millinewton
- mV:
-
Millivolt
- cAMP:
-
cyclisches Adenosin-3′,5′-monophosphat
- cGMP:
-
cyclisches Guanosin-3′,5′-monophosphat
- PIA:
-
(-)-N6-Phenylisopropyladenosin
- NECA:
-
5′-N-Äthylcarboxamidadenosin
Literatur
Baer HP, Muller MJ, Munishi R (1982) Adenosine receptors in smooth muscle. Naunyn-Schmiedeberg's Arch Pharmacol 321:R 10
Baer HP, Muller MJ, Friend R, Murji A, Munshi R (1985) Mechanism of action of adenosine and adenosine derivatives in smooth muscle: involvement of adenylate cyclase? In: Stefanovich V, Rudolphi K, Schubert P (eds) Adenosine: Receptors and modulation of cell function. IRL Press, Oxford, pp 247–260
Bagdonas AA, Stuckey JH, Plera J, Amer NS, Hoffmann BF (1961) Effects of ischemia and hypoxia on the specialized conducting system of the canine heart. Am Heart J 61:206–218
Baumann G, Schrader J, Gerlach E (1981) Inhibitory action of adenosine on histamine- and dopamine-stimulated cardiac contractility and adenylate cyclase in guinea pigs. Circ Res 48:258–266
Belardinelli L, Belloni FL, Rubio R, Berne RM (1980) Atrioventricular conduction disturbances during hypoxia: Pssible role of adenosine in rabbit and guinea-pig heart. Circ Res 47:684–691
Belardinelli L, Mattos EC, Berne RM (1981) Evidence for adenosine mediation of atrioventricular block in ischemic canine myocardium. J Clin Invest 68:195–205
Belardinelli L, Fenton R, West A, Linden J, Althaus JS, Berne RM (1982) Extracellular action of adenosine and the antagonism by aminophylline on the atrioventricular conduction in the isolated perfused guinea pig and rat hearts. Circ Res 51:569–579
Belardinelli L, Vogel S, Linden J, Berne RM (1982) Antiadrenergic actions of adenosine on ventricular myocardium in embryonic chick hearts. J Mol Cell Cardiol 14:291–294
Belardinelli L, Isenberg G (1983) Isolated atrial myocytes: Adenosine and acetylcholine increase potassium conductance. Am J Physiol 244:H734–H737
Belardinelli L, West A, Crampton R, Berne RM (1983) Chronotropic and dromotropic effects of adenosine. In: Berne RM, Rall TW, Rubio R (eds) Regulatory function of adenosine. pp 377–398. Martinus Nijhoff Publishers, The Hague Boston London
Belhassen B, Pelleg A, Shoshani D, Geva B, Laniado S (1983) Electrophysiologic effects of adenosine-5′-triphosphate on atrioventricular reentrant tachycardia. Circulation 68:827–833
Belhassen B, Pelleg A (1984) Electrophysiological effects of adenosine triphosphate and adenosine in the mammalian heart: Clinical and experimental aspects. J Am Coll Cardiol 4:414–424
Belhassen B, Pelleg A (1984) Acute management of paroxysmal supraventricular tachycardia: Verapamil, adenosine triphosphate or adenosine? Am J Cardiol 54:225–227
Benditt DG, Benson DW Jr, Kreitt J, Dunnigan A, Pritzker MR, Crouse L, Scheinmann MM (1983) Electrophysiologic effects of theophylline in young patients with recurrent symptomatic bradyarrhythmias. Am J Cardiol 52:1223–1229
Berne RM (1963) Cardiac nucleotides in hypoxia: Possible role in regulation of coronary blood flow. Am J Physiol 204:317–322
Berne RM (1980) The role of adenosine in the regulation of coronary blood flow. Circ Res 47:807–813
Berne RM, DiMarco JP, Belardinelli L (1984) Dromotropic effects of adenosine and adenosine antagonists in the treatment of cardiac arrhythmias involving the atrioventricular node. Circulation 69:1195–1197
Berne RM, Belardinelli L (1984) Effects of hypoxia and ischemia on coronary vascular resistance, A-V node conduction and S-A node excitation. Acta Med Scand (Suppl) 694:9–19
Böhm M, Brückner R, Hackbarth I, Haubitz B, Linhart R, Meyer W, Schmidt B, Schmitz W, Scholz H (1984) Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect. J Pharmacol Exp Ther 230:483–492
Böhm M, Brückner R, Meyer W, Nose M, Schmitz W, Scholz H, Starbatty J (1985) Evidence for adenosine receptor-mediated isoprenaline-antagonistic effects of the adenosine analogs PIA and NECA on force of contraction in guinea-pig atrial and ventricular cardiac preparations. Naunyn-Schmiedeberg's Arch Pharmacol 331:131–139
Böhm M, Burmann H, Meyer W, Schmitz W, Scholz H (1985) Positive inotropic effects of Bay K 8644: cAMP-independence and lack of inhibitory effect of adenosine. Naunyn-Schmiedeberg's Arch Pharmacol 329:447–450
Böhm M, Meyer W, Mügge A, Schmitz W, Scholz H (1985) Functional evidence for the existence of adenosine receptors in the human heart. Eur J Pharmacol 116:323–326
Böhm M, Wilken A (1986) Pertussis toxin pretreatment prevents adenosine- and carbachol-mediated AV conduction block in guinea-pig hearts. Naunyn-Schmiedeberg's Arch Pharmacol 332:R 46
Böhm M, Brückner R, Neumann J, Schmitz W, Scholz H, Starbatty J (1986) Role of guanine nucleotide-binding protein in the regulation by adenosine of cardiac potassium conductance and force of contraction. Evaluation with pertussis toxin. Naunyn-Schmiedeberg's Arch Pharmacol 332:403–405
Böhm M, Mende U, Schmitz W, Scholz H (1986) Increased sensitivity to α-adrenoceptor stimulation but intact muscarinergic and purinergic effects in prehypertensive cardiac hypertrophy of spontaneously hypertensive rats. Naunyn-Schmiedeberg's Arch Pharmacol 333:284–289
Böhm M, Mende U, Schmitz W, Scholz H (1986) Does an impaired adenosine-mediated feed back control play a role in the pathogenesis of hereditary dystrophic cardiomyopathy of the Syrian hamster? Cardiovasc Res 20:568–573
Boulanger J-P, Marangos PJ, Patel J, Uhde TW, Post RM (1984) Central adenosine receptors: Possible involvement in the chronic effects of caffeine. Psychopharmacol Bull 20:431–435
Brückner R, Fenner A, Meyer W, Nobis T-M, Schmitz W, Scholz H (1985) Cardiac effects of adenosine and adenosine analogs in guinea-pig atrial and ventricular preparations. Evidence against a role of cAMP and cGMP. J Pharmacol Exp Ther 234:766–774
Bruns RF, Daly JW, Snyder SH (1983) Adenosine receptor binding: Structure activity analysis generates extremely potent xanthine antagonists. Proc Natl Acad Sci USA 50:2077–2080
Chiba S, Himori N (1975) Different inotropic responses to adenosine on the atrial and ventricular muscle of the dog heart. Jpn J Pharmacol 25:489–491
Cockcroft S, Gomperts BD (1985) Role of guanine nucleotide binding protein in the activation of polyphosphoinositide phosphodiesterase. Nature 314:534–536
Collis MG (1983) Evidence forA 1-adenosine receptors in the guinea-pig atrium. Br J Pharmacol 78:207–212
Collis MG, Saville VL (1984) An investigation of the negative chronotropic effect of adenosine in the guinea-pig atrium. Br J Pharmacol 83:413
Cranefield PF (1975) The conduction of the cardic impulse. Futura Publishing company, Mount Kisko New York, pp 75–115
de Gubareff T, Sleator W (1965) Effects of caffeine on mammalian atrial muscle and its interaction with adenosine and calcium. J Pharmacol Exp Ther 148:201–214
DiMarco JP, Sellers TD, Berne RM, West GA, Belardinelli L (1983) Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardias. Circulation 68:1254–1263
DiMarco JP, Sellers TD, Lerman BB, Greenberg ML, Berne RM, Belardinelli L (1985) Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol 6:417–425
Dobson JG jr (1978) Reduction by adenosine of the isoproterenol-induced increase in cyclic adenosine-3′,5′-monophosphate formation and glycogen phosphorylase activity in rat heart muscle. Circ Res 43:785–792
Dobson JG jr (1983) Mechanism of adenosine inhibition of catecholamine-induced responses in heart. Circ Res 52:151–160
Dobson JG jr, Ordway W, Fenton RA (1986) Endogenous adenosine inhibits catecholamine contractile responses in normoxic hearts. Am J Physiol 251:H455–H462
Drury AN, Szent-Györgyi A (1929) The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol (Lond) 68:213–237
Endoh M, Yamashita S (1980) Adenosine antagonizes the inotropic action mediated via β- but not α-adrenoceptors in the rabbit papillary muscle. Eur J Pharmacol 65:445–448
Endoh M, Maruyama M, Taira N (1983) Modification by islet-activating protein of direct and indirect inhibitory actions of adenosine on rat atrial contraction in relation to cyclic nucleotide metabolism. J Cardiovasc Pharmacol 5:131–142
Endoh M, Maruyama M, Taira N (1983) Adenosine-induced changes in rate of beating and cyclic nucleotide levels in rat atria: Modification by islet-activating protein. In: Daly JW, Kuroda Y, Phillis JW, Shimizu H, Ui M (eds) Physiology and pharmacology of adenosine. Raven press, New York, pp 127–140
Endoh M, Maruyama M, Ijima T (1985) Attentuation of muscarinic cholinergic inhibition by islet-activating protein in the heart. Am J Physiol 249:H309–H320
Evans DB, Schenden JA, Bristol JA (1982) Adenosine receptors mediating cardiac depression. Life Sci 31:2425–2432
Favale S, Di Biase M, Rizzo U, Belardinelli L, Rizzon P (1985) Effect of adenosine and adenosine-5-triphosphate on atrioventricular conduction in patients. J Am Coll Cardiol 5:1212–1219
Fernandez-Rivera-Rio L, Gonzalez-Garcia MaR (1985) The human erythrocyte ghost: A new experimental model for studying adenosine transport. Arch Biochem Biophys 240:246–256
Foley DH, Herlihy JT, Thompson CI, Rubio R, Berne RM (1978) Increased adenosine formation by rat myocardium with acute aortic constriction. J Mol Cell Cardiol 10:293–300
Fox AC, Reed GE, Glassman E, Kaltman AJ, Silk BB (1974) Release of adenosine from human hearts during angina induced by rapid atrial pacing. J Clin Invest 53:1447–1457
Fredholm BB (1985) Adenosine and central catecholamine neurotransmission. In: Stefanovich V, Rudolphi K, Schubert P (eds) Adenosine: Receptors and modulation of cell function. IRL Press, Oxford, pp 91–106
Fredholm BB, Sollevi A (1986) Cardiovascular effects of adenosine. Clin Physiol 6:1–21
Gomperts BD (1983) Involvement of guanine nucleotide-binding protein in the gating of Ca2+ by receptors. Nature 306:64–66
Grossman A, Furchgott RF (1964) The effect of various drugs on calcium exchange in the isolated guinea-pig left auricle. J Pharmacol Exp Ther 145:162–172
Hazeki O, Ui M (1981) Modification by islet-activating protein of receptor-mediated regulation of cyclic AMP accumulation in isolated rat heart cells. J Biol Chem 256:2856–2862
Hollander P, Webb JL (1957) Effects of adenine nucleotides on the contractility and membrane potentials of rat atrium. Circ Res 5:349–353
Honey RM, Richie WT, Thomson WAR (1930) The action of adenosine on the human heart. Q J Med 23:485–489
Hopkins SV (1973) The potentiation of the action of adenosine on the guinea-pig heart. Biochem Pharmacol 22:341–348
Hosey MM, McMahon KK, Green RD (1984) Inhibitory adenosine receptors in the heart: Characterization by radioligand binding studies and effects on β-adrenergic stimulated adenylate cyclase and membrane proteine phosphorylation. J Mol Cell Cardiol 16:931–942
Huang M, Drummond GI (1976) Effects of adenosine on cyclic AMP accumulation in ventricular myocardium. Biochem Pharmacol 25:2713–2719
Huang M, Drummond GI (1978) Interaction between adenosine and catecholamines on cyclic AMP accumulation in guinea pig ventricular myocardium. Biochem Pharmacol 27:187–191
Huang M, Drummond GI (1978) Effect of adenosine and catecholamines on cyclic AMP levels in guinea pig hearts. Adv Cyclic Nucleotide Res 9:341–353
Hughes PR, Stone TW (1983) Inhibition by purines of the inotropic action of isoprenaline in rat atria. Br J Pharmacol 80:149–153
Hutter OF, Rankin OC (1982) Increase by adenosine and adenine nucleotides in potassium permeability in sinus venosus of tortoise heart. J Physiol (Lond) 329:57P-58P
Isenberg G, Belardinelli L (1984) Ionic basis for the antagonism between adenosine and isoproterenol on isolated ventricular myocytes. Circ Res 55:309–325
Jakobs AJ, Aktories K, Schultz G (1984) Mechanism of pertussis toxin action on the adenylate cyclase system. Eur J Biochem 140:177–181
Jochem G, Nawrath H (1983) Adenosine activates a potassium conductance in atrial heart muscle. Experientia 39:1347–1349
Johnson EA, McKinnon MG (1956) Effect of acetylcholine and adenosine on cardiac cellular potentials. Nature (London) 178:1174–1175
Klabunde RE (1983) Dipyridamole inhibition of adenosine metabolism in human blood. Eur J Pharmacol 93:21–26
Leclerq JF, Coumel P (1978) Les effects de l'adenosine triphosphorique (ATP) sur le noeud sinusual et le noeud auriculo-ventriculaire chez l'homme Variation selon le lieu d'injection. Ceour Med Interne 17:541–546
Linden J, Hollen CE, Patel A (1985) The mechanism by which adenosine and cholinergic agents reduce contractility in rat myocardium. Correlation with cyclic adenosine monophosphate and receptor densities. Circ Res 56:728–735
Lohse MJ, Lenschow V, Schwabe U (1984) Two affinity states of adenosine Ri receptors in brain: Analysis of guanine nucleotide and temperature effects. Mol Pharmacol 26:1–9
Lohse MJ, Ukena D, Schwabe U (1985) Demonstration of Ri-type adenosine receptors in bovine myocardium by radioligand binding. Naunyn-Schmiedeberg's Arch Pharmacol 328:310–316
Londos C, Wolff J (1977) Two distinct adenosine-sensitive sites on adenylate cyclase. Proc Natl Acad Sci USA 74:5482–5486
Londos C, Wolff J, Cooper DMF (1979) Action of adenosine on adenylate cyclase. In: Baer HP, Drummond GI (eds) Physiological and regulatory functions of adenosine and adenine nucleotides. Raven Press, New York, pp 271–281
Londos C, Cooper DMF, Wolff J (1980) Subclasses of external adenosine receptors. Proc Natl Acad Sci USA 77:2551–2554
Malbon CC, Mangano TJ, Watkins DC (1985) Heart contains two substrates (Mr=40,000 and Mr=41,000) for pertussis toxin-catalyzed ADP-ribosylation that co-purify with Ns. Biochem Biophys Res Comm 128:809–815
McKenzie SJ, Frew R, Bär HP (1977) Characteristics of the relaxant response of adenosine and its analogs in the intestinal smooth muscle. Eur J Pharmacol 41:183–192
McKenzie SJ, Frew R, Bär HP (1977) Effect of adenosine and related compounds on adenylate cyclase and cyclic AMP levels in smooth muscle. Eur J Pharmacol 41:193–202
McKenzie JE, McCoy FP, Bockman EL (1981) Myocardial adenosine and coronary resistance during increased cardiac performance. Am J Physiol 239:H509–515
Meinertz T, Nawrath H, Scholz H (1973) Influence of cyclization and acyl substitution on the inotropic effects of adenine nucleotides. Naunyn-Schmiedeberg's Arch Pharmacol 278:165–178
Nakamura T, Ui M (1984) Islet-activating protein, pertussis toxin, inhibits Ca2+-induced and guanine nucleotide-dependent releases of histamine and arachidonic acid from rat mast cells. FEBS Lett 173:414–418
Nawrath H (1976) Cyclic AMP and cyclic GMP may play opposing roles in influencing force of contraction in mammalian myocardium. Nature (Lond) 262:509–511
Nawrath H, Jochem G, Sack U (1985) Inotropic effects of adenosine in guinea-pig myocardium. In: Stefanovich V, Rudolphi K, Schubert P (eds) Adenosine: Receptors and modulation of cell function. IRL Press, Oxford, pp 323–340
Pelleg A (1985) Cardiac cellular electrophysiological effects of adenosine and adenosine triphosphate. Am Heart J 110:688–693
Pfaffinger PJ, Martin JM, Hunter DD, Nathanson NM, Hille B (1985) GTP-binding proteins couple cardiac muscarinic receptors to a K channel. Nature 317:536–538
Radulovacki M (1985) Role of adenosine in sleep in rats. In: Stefanovich V, Rudolphi K, Schubert P (eds) Adenosine: Receptors and modulation of cell function. IRL Press, Oxford, pp 211–220
Rockoff JB, Dobson JG jr (1980) Inhibition by adenosine of catecholamine-induced increase in rat atrial contractility. Am J Physiol 239:H365–H370
Rodbell M (1980) The role of hormone receptors and GTP-regulatory proteins in membrane transduction. Nature 284:17–22
Schmitz W, Böhm M, Brückner R, Burmann H, Meyer W, Neumann J, Nose M, Scholz H (1985) Relationship between the effects of cAMP-increasing agents and adenosine in the mammalian heart. In: Stefanovich V, Rudolphi K, Schubert P (eds) Adenosine: Receptors and modulation of cell function. IRL Press, Oxford, pp 295–305
Scholz H, Böhm M, Meyer W, Schmitz W (1986) On the mechanism of the cardiotonic and smooth muscle relaxant effects of the methylxanthines. In: Bader H, Gietzen H, Rosenthal L, Rüdel R, Wolf HU (eds) Intracellular calcium regulation. Manchester University Press, Manchester, pp 447–460
Schrader J, Rubio R, Berne RM (1975) Inhibition of slow action potentials of guinea pig atrial muscle by adenosine: A possible effect on Ca2+ influx. J Mol Cell Cardiol 7:427–433
Schrader J, Baumann G, Gerlach E (1977) Adenosine as inhibitor of myocardial effects of catecholamines. Pflügers Arch 372:29–35
Schrader J, Haddy FJ, Gerlach E (1977) Release of adenosine, inosine and hypoxanthine from the isolated guinea pig heart during hypoxia, flow-autoregulation and reactive hyperemia. Pflügers Arch 369:1–6
Schrader J, Nees S, Gerlach E (1977) Evidence for a cell surface adenosine receptor on coronary myocytes and atrial muscle cells. Pflüger's Arch 369:251–257
Schütz W, Tuisl E (1981) Evidence against adenylate cyclase-coupled adenosine receptors in the guinea pig heart. Eur J Pharmacol 76:285–288
Schwabe U (1983) General aspects of binding of ligands to adenosine receptors. In: Berne RM, Rall TW, Rubio R (eds) Regulatory functions of adenosine. Martinus Nijhoff Publishers, The Hague, Boston, London, pp 77–96
Schwabe U (1985) Classification of adenosine receptors. In: Stefanovich V, Rudolphi K, Schubert P (eds) Adenosine: Receptors and modulation of cell function. IRL Press, Oxford, pp 15–28
Senges J, Mizutani T, Pelzer D, Brachmann J, Sonnhof U, Kübler W (1979) Effect of hypoxia on the sinuatrial node, atrium, and atrioventricular node in the rabbit heart. Circ Res 44:856–863
Shah A, Kechejian SJ, Kavaler F, Fisher VJ (1974) Effects of adenine nucleotides on contractility of normal and post-ischemic myocardium. Am Heart J 87:740–749
Snyder SH, Sklar P (1984) Behavioral and molecular actions of caffeine: Focus on adenosine. J Psychiat Res 18:92–106
Sparks HV, Bardenheuer H (1986) Regulation of adenosine formation by the heart. Circ Res 58:193–201
Szentmiklósi AJ, Szegi I, Nemeth M, Papp J Gy, Szekeres L (1978) Does adenosine exert any effect on heart ventricle? Abstracts of the Seventh International Congress of Pharmacology, Paris, p 981
Szentmiklósi AJ, Nemeth M, Szegi I, Papp J Gy, Szekeres L (1979) On the possible role of adenosine in hypoxia-induced alterations of the electrical and mechanical activity of the atrial myocardium. Arch Int Pharmacodyn 238:283–295
Szentmiklósi AJ, Nemeth M, Szegi I, Papp J Gy, Szekeres L (1980) Effect of adenosine on sinuatrial and ventricular automaticity of the guinea-pig. Naunyn-Schmiedeberg's Arch Pharmacol 311:147–149
Szentmiklósi AJ, Kovacs T, Cseppento A, Szegi J (1983) On the possible mechanism underlying the inhibitory action of adenosine (AD) in atrial myocardium of guinea pig. In: Berne RM, Rall TW, Rubio R (eds) Regulatory function of adenosine. Martinus Nijhoff Publishers, The Hague Boston London, p 543
Trost T, Stock K (1977) Effects of adenosine derivatives on cAMP accumulation and lipolysis in rat adipocytes and on adenylate cyclase on adipocyte plasma membranes. Naunyn-Schmiedeberg's Arch Pharmacol 299:33–40
Ukena D, Poeschla E, Schwabe U (1984) Guanine nucleotide and cation regulation of radioligand binding to Ri adenosine receptors in rat fat cells. Naunyn-Schmiedeberg's Arch Pharmacol 326:241–247
Urthaler F, James TN (1972) Effects of adenosine and ATP on AV conduction and on AV junctional rhythm. J Lab Clin Med 79:96–105
Van Calker D, Muller N, Hamprecht B (1979) Adenosine regulates by two different types of receptors the accumulation of cyclic AMP in cultured brain cells. J Neurochem 33:999–1005
Watanabe AM, Besch HR (1974) Cyclic adenosine monophosphate modulation of slow calcium influx channels in guinea-pig hearts. Circ Res 35:316–324
Watt AH (1984) Hypertrophic cardiomyopathy: a disease of impaired adenosine-mediated autoregulation of the heart. Lancet 1:1271–1273
Wesley RC jr, Lerman BB, DiMarco JP, Berne RM, Belardinelli L (1986) Mechanism of atropine-resistant atrioventricular block during inferior myocardial infarction: Possible role of adenosine. J Am Coll Cardiol 8:1232–1234
West GA, Belardinelli L (1985) Sinus slowing and pacemaker shift caused by adenosine in rabbit SA node. Pfluegers Arch 403:66–74
West GA, Belardinelli L (1985) Correlation of sinus slowing and hyperpolarization caused by adenosine in sinus node. Pfluegers Arch 403:75–81
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Böhm, M. Kardiale Wirkungen von Adenosin. Klin Wochenschr 65, 487–499 (1987). https://doi.org/10.1007/BF01721034
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01721034